A. Richter

发表

Monitoring of Plasmin and Plasminogen Activator Activity in Blood of Patients under Fibrinolytic Treatment by Reteplase

H. Renz, B. Maisch, T. Stief, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy.

W. Haverkamp, R. Dietz, B. Erdmann, 2008, Molecular genetics and metabolism.

Novel mutations in the sarcomeric protein myopalladin in patients with dilated cardiomyopathy

T. Meyer, S. Sperling, V. Ruppert, 2012, European Journal of Human Genetics.

Mitochondrial disorders with cardiac dysfunction: an under-reported aetiology with phenotypic heterogeneity.

S. Pankuweit, A. Richter, 2015, European heart journal.

The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure

V. Ruppert, K. Schlüter, S. Pankuweit, 2018, Open Heart.

Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy

G. Gelbrich, V. Ruppert, B. Maisch, 2015, European journal of clinical investigation.

Management of Patients with Suspected (Peri-)Myocarditis and Inflammatory Dilated Cardiomyopathy

B. Maisch, P. Alter, S. Pankuweit, 2006, Herz Kardiovaskuläre Erkrankungen.

Evidence for CTLA4 as a susceptibility gene for dilated cardiomyopathy

T. Meyer, V. Ruppert, B. Maisch, 2010, European Journal of Human Genetics.

Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy

M. Böhm, R. Dietz, N. Duong, 2008, Basic Research in Cardiology.

Identification of a missense mutation in the melusin-encoding ITGB1BP2 gene in a patient with dilated cardiomyopathy.

T. Meyer, V. Ruppert, B. Maisch, 2013, Gene.

Genotype‐specific effects on left ventricular function in parvovirus B19‐positive patients with dilated cardiomyopathy

T. Meyer, V. Ruppert, B. Maisch, 2011, Journal of medical virology.

Isolated Cardiac Sarcoidosis Associated with the Expression of a Splice Variant Coding for a Truncated BTNL2 Protein

T. Meyer, V. Ruppert, B. Maisch, 2007, Cardiology.

Inflammatory Dilated Cardiomyopathy (DCMI)

B. Maisch, S. Pankuweit, A. Richter, 2005, Herz Kardiovaskuläre Erkrankungen.

Clinical genetics of dilated cardiomyopathy: on the way to personalized medicine?

S. Pankuweit, A. Richter, 2015, European heart journal.

[Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].

V. Ruppert, B. Maisch, S. Pankuweit, 2009, Herz.

Detection of a large duplication mutation in the myosin-binding protein C3 gene in a case of hypertrophic cardiomyopathy.

T. Meyer, V. Ruppert, B. Maisch, 2013, Gene.

Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy.

R. Dietz, V. Ruppert, B. Maisch, 2007, Molecular genetics and metabolism.

Viral genomes in the pericardial fluid and in peri- and epicardial biopsies from a German cohort of patients with large to moderate pericardial effusions

V. Ruppert, B. Maisch, K. Karatolios, 2013, Heart Failure Reviews.

Familial inflammatory dilated cardiomyopathy

V. Ruppert, B. Maisch, S. Pankuweit, 2006, European journal of heart failure.

Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy

C. Hengstenberg, E. Arbustini, J. Cleland, 2019, Heart.

Genetic Association Study Identifies HSPB7 as a Risk Gene for Idiopathic Dilated Cardiomyopathy

I. König, L. Fauchier, V. Regitz-Zagrosek, 2010, PLoS genetics.

In vitro Simulation of Therapeutic Plasmatic Fibrinolysis

H. Renz, B. Maisch, J. Fareed, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cardiomyopathies: classification, diagnosis, and treatment.

V. Ruppert, B. Maisch, S. Pankuweit, 2012, Heart failure clinics.

Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy

S. Störk, V. Holzendorf, K. Karatolios, 2018, Disease markers.

Autoimmunity in dilated cardiomyopathy

M. Herzum, B. Maisch, Bernhard Maisch, 1996, Heart Failure Reviews.

Cardiomyopathies : Classification, and Treatment

V. Ruppert, B. Maisch, S. Pankuweit, 2012 .

Clinical predictors of outcome in patients with inflammatory dilated cardiomyopathy

D. Tousoulis, V. Holzendorf, K. Karatolios, 2017, PloS one.

Anticardiac Antibodies in Patients with Chronic Pericardial Effusion

V. Ruppert, B. Maisch, K. Karatolios, 2016, Disease markers.

Biventricular unloading in patients with refractory cardiogenic shock.

K. Karatolios, B. Schieffer, A. Richter, 2016, International journal of cardiology.

Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.

L. Fauchier, L. Tavazzi, E. Arbustini, 2009, European heart journal.

Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

L. Mestroni, M. Komajda, W. McKenna, 1999, European heart journal.

Monitoring of Functional Plasminogen in the Blood of Patients on Fibrinolytics

H. Renz, B. Maisch, T. Stief, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Long-term outcome and predictors of outcome in patients with non-ischemic dilated cardiomyopathy.

V. Holzendorf, K. Karatolios, S. Pankuweit, 2016, International journal of cardiology.

Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.

L. Fauchier, L. Tavazzi, E. Arbustini, 2009, European heart journal.

PREVALENCE OF DIFFERENT ETIOLOGIES IN DILATED CARDIOMYOPATHY

V. Ruppert, B. Maisch, S. Pankuweit, 2010 .

Mitochondrial disorders with cardiac dysfunction: an under-reported aetiology with phenotypic heterogeneity.

S. Pankuweit, A. Richter, 2015, European heart journal.

Functional Determination of Plasminogen Activatorin Arginine-stabilized Plasma

H. Renz, B. Maisch, T. Stief, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Functional Determination of Plasminin Arginine-stabilized Plasma

H. Renz, B. Maisch, T. Stief, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.